Confo Therapeutics Alternatives & Competitors
12 companies similar to Confo Therapeutics — Exploiting the conformational complexity of GPCRs to innovate drug discovery
Companies similar to Confo Therapeutics
EnPlusOne Biosciences
Harnessing the power and flexibility of enzymes to deliver RNA to the world
Watertown, United States
Eli Lilly and Company
Discovery, development, manufacture, and sale of products in pharmaceutical products busin...
Indianapolis, United Stat...
BlueRock Therapeutics
Striving to transform the treatment of disease by harnessing the power of cell therapy
Cambridge, United States
Boehringer Ingelheim
Boehringer Ingelheim - researching, developing, manufacturing and marketing of pharmaceuti...
Germany
Track all Confo Therapeutics competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
REGENXBIO
Seeking to improve lives through the curative potential of gene therapy.
Rockville, United States
Anocca
Engineered Immunity
Sodertalje, Sweden
Rinati Skin, LLC
Harnessing our cutting-edge stem cell technology to improve lives through novel, unique an...
Beverly Hills, United Sta...
C4 Therapeutics, Inc.
Clinical-stage biotech company transforming how disease is treated through targeted protei...
Watertown, United States
Enara Bio
Advancing cancer immunotherapy by targeting the unconventional
Oxford, United Kingdom
Avenzo Therapeutics
Developing the next generation of oncology therapies for patients
San Diego, United States
NOVADIP Biosciences S.A.
Novadip is transforming the lives of patients using its unique 3M³ tissue regeneration tec...
Belgium
Emalex Biosciences
Improving people's lives impacted by central nervous system disorders through meaningful s...
Chicago, United States
About Confo Therapeutics
Confo Therapeutics, founded in 2015 and headquartered in Belgium, is a pioneering biotechnology company that leverages its proprietary technology platform to stabilize functional conformations of GPCRs (G protein-coupled receptors). This innovative approach uncovers a vast array of previously inaccessible GPCRs as pote...
Development of GPCR-modulating therapies, Clinical research and development, Partnership with pharmaceutical companies, Small molecules and antibody therapeutics development, GPCR targeting technology innovation
Patients with metabolic diseases, Patients with endocrine diseases, Pharmaceutical companies, Healthcare providers specializing in pain management, Research institutions
GPCR Drug Discovery, Conformational Stabilization, Biopharmaceuticals, Drug Candidates Development, Severe Illness Therapeutics, Disease-Modifying Treatments, Pharmacologic Insight, Biologic Insight, Innovative Drug Targets, CONFO® Technology, Active State Conformations, Novel Agonist Discovery, Antibody Technology, Multi-Indication Pipeline, Unmet Medical Needs
B2B, White Label
Licensing, Performance Based, Product Sales
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Confo Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Confo Therapeutics on 15 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
